Biren Saraiya, MD

Biren Saraiya, MD, is a medical oncologist at Rutgers Cancer Institute.

Articles by Biren Saraiya, MD

Upfront Combos Show Promise in Prostate Cancer, But Questions Remain

June 27th 2025

Biren Saraiya, MD, discusses how he sees findings from the phase 3 AMPLITUDE trial being incorporated into clinical practice for the treatment of metastatic castration-sensitive prostate cancer.

Dr Saraiya on the AMPLITUDE Trial in mCSPC

ByBiren Saraiya, MD

June 27th 2025

Biren Saraiya, MD, provides background on the phase 3 AMPLITUDE study evaluating niraparib plus abiraterone acetate in metastatic castration-sensitive prostate cancer.

Biren Saraiya, MD

Articles by Biren Saraiya, MD

Upfront Combos Show Promise in Prostate Cancer, But Questions Remain

Dr Saraiya on the AMPLITUDE Trial in mCSPC

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL

Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC

Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma

Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma

JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update